[REVISION HISTORY]

Vitamin D and brain health research

Updated 5 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-08 05:23 UTC → 2026-09-12 11:03 UTC · added ~~removed~~

In late July 2026, research emerged highlighting the complex relationship between vitamin D and cognitive health across different age groups and conditions. A Rutgers University trial involving overweight or obese women aged 50–70 found that a moderate daily dose of 2,000 IU improved memory and learning compared to the standard 600 IU dose. However, both the 2,000 IU and 4,000 IU doses were associated with slower reaction times, which researchers noted could increase the risk of falls in older adults. Simultaneously, an analysis of the Framingham Heart Study—published in Neurology Open Access—linked higher midlife vitamin D levels (measured at an average age of 39) to significantly lower accumulation of tau protein, a key marker of Alzheimer’s disease. This observational study of 793 dementia-free adults found no association with amyloid-beta deposits and emphasized that the results were correlational rather than causal. In August 2026, findings published in ‘Sleep Medicine’ by Emory University researchers reinforced observations regarding high-dose supplementation. In a study of 54 adults aged 50 and older with mild cognitive impairment (MCI) and sleep disorders, those taking at least 5,000 IU of Vitamin D3 or D2 daily showed an average 3.78-point increase (approximately 13%) on the Montreal Cognitive Assessment (MoCA) compared to non-supplementers. Researchers cautioned that these findings are preliminary and observational, noting that the 5,000 IU dose exceeds the generally recommended 4,000 IU maximum intended to prevent hypercalcemia. In September 2026, further research highlighted potential links to other neurodegenerative conditions. A 2013 observational study of 286 Parkinson's patients indicated that higher blood levels of vitamin D were associated with better memory performance and fewer depressive symptoms, though researchers noted this does not prove supplementation can slow disease progression.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.